Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Negar Chooback"'
1
Population-Based Analysis of Outcomes for Patients With Brain Metastases From Epidermal Growth Factor Receptor Mutation Positive Non-Small Cell Lung Cancer Treated With Tyrosine Kinase Inhibitor Alone or Combined With Radiotherapy
Autor: Alan Nichol, Timothy Kong, A. Benny, Cheryl Ho, Lovedeep Gondara, Negar Chooback, I.M. Fraser, Shilo Lefresne
Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 111:e569-e570
Purpose/Objective(s) With modern therapies, the median survival of patients with brain metastases (BrM) from non-small cell lung cancer (NSCLC) with epidermal growth factor receptor mutation (EGFRm) may exceed 1-2 years. BrM directed therapies must t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::90a480619c0d92ac0b894c788966da45
https://doi.org/10.1016/j.ijrobp.2021.07.1538
Zobrazit plný text záznamu
3
Outcome Differences Between First- and Second-generation EGFR Inhibitors in Advanced EGFR Mutated NSCLC in a Large Population-based Cohort
Autor: Negar Chooback, Cheryl Ho, Barbara Melosky, S. Lau
Publikováno v: Clinical lung cancer. 20(5)
Introduction Second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) appear superior to first-generation TKIs in clinical trials, but at the cost of greater toxicity. It is unclear whether real-world patients, who
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e637a1db2fdb26c967ac988ba35dc8ed
https://pubmed.ncbi.nlm.nih.gov/31178389
Zobrazit plný text záznamu
4
Palliative thoracic radiotherapy near the end of life in lung cancer: A population-based analysis
Autor: I.M. Fraser, Negar Chooback, Jacqueline Regan, Robert Olson, Cheryl Ho, Shilo Lefresne, Eric Berthelet
Publikováno v: Lung cancer (Amsterdam, Netherlands). 135
Objectives Palliative thoracic radiotherapy (RT) can improve quality of life for patients with advanced lung cancer, but treatment can be associated with acute toxicity and symptomatic relief may take several weeks. The optimal fractionation schedule
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8745e73266094bef0baacf0b0c7a5b74
https://pubmed.ncbi.nlm.nih.gov/31447009
Zobrazit plný text záznamu
5
CNS Metastases in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: Impact on Health Resource Utilization
Autor: Negar Chooback, Cheryl Ho, Shilo Lefresne, S. Lau
Publikováno v: Journal of oncology practice. 14(10)
Purpose: Patients with epidermal growth factor receptor (EGFR) mutation–positive (EGFRm) non–small-cell lung cancer commonly experience disease progression in the CNS. Here, we assess the impact of CNS disease on resource utilization and outcomes
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf1d5d0b39737e7ce0139018f6ad12fb
https://pubmed.ncbi.nlm.nih.gov/30216125
Zobrazit plný text záznamu
6
Canadian Lung Cancer Conference 2017
Autor: Negar Chooback, Barbara Melosky, Cheryl Ho
Publikováno v: Current Oncology
Volume 24
Issue 4
Pages 3660-338
The 2017 Canadian Lung Cancer Conference was held 9&ndash
10 February in Vancouver, British Columbia. Each year at this prestigious event, hundreds of professionals involved in lung cancer care come together to discuss new research, to learn abo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e554b03625abd4e4ddd984ae1232e8
https://europepmc.org/articles/PMC5576474/
Zobrazit plný text záznamu
7
Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy
Autor: M. Jones, T. Thomson, M. Martín, Y. Shen, Negar Chooback, Marco A. Marra, T. Ng, Janessa Laskin, Cheryl Ho, Katayoon Kasaian
Publikováno v: Current Oncology
Volume 24
Issue 3
Pages 3588-254
The most common benign salivary tumour is a pleomorphic adenoma. Transformation to malignancy, carcinoma ex pleomorphic adenoma (cxpa), occurs in 6% of cases. Management focuses on surgical resection and radiotherapy
however, rare cases require
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a0197d057ff1178b1ebddfabec246bb
https://pubmed.ncbi.nlm.nih.gov/28680294
Zobrazit plný text záznamu
8
Clinical outcomes after whole-genome sequencing in patients with metastatic non-small-cell lung cancer
Autor: Daniel J. Renouf, Sophie Sun, Yaoqing Shen, Yussanne Ma, Cheryl Ho, Janessa Laskin, Howard John Lim, Negar Chooback, Stephen Yip, Yongjun Zhao, Richard D. Moore, Andrew J. Mungall, Erin Pleasance, Marco A. Marra, Erica S Tsang, Katayoon Kasaian, Diana N. Ionescu, Steven J.M. Jones, Karen Mungall, Martin L. Jones
Publikováno v: Cold Spring Harbor Molecular Case Studies
The Personalized Onco-Genomics (POG) program at BC Cancer integrates whole-genome (DNA) and RNA sequencing into practice for metastatic malignancies. We examined the subgroup of patients with metastatic non-small-cell lung cancer (NSCLC) and report t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::064a4b2994fa46407648828ec0e8b315
https://doi.org/10.1101/mcs.a002659
Zobrazit plný text záznamu
9
Whole genome and transcriptome sequencing of lung cancer: Options for personalized cancer treatment
Autor: Yongjun Zhao, Janessa Laskin, Cheryl Ho, Daniel J. Renouf, Marco A. Marra, Karen A. Gelmon, Negar Chooback, Howard John Lim, Andrew J. Mungall, Stephen Yip, Erica S Tsang, Steven J.M. Jones, Richard A. Moore, Yaoqing Shen
Publikováno v: Journal of Clinical Oncology. 35:e20567-e20567
e20567 Background: Targeted therapy against driver mutations has revolutionized lung cancer management. The Personalized OncoGenomics (POG) program uses whole genome and transcriptome derived information to build pathways and identify potential thera
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9c291b27e1e270208f75a8857b4fd7c0
https://doi.org/10.1200/jco.2017.35.15_suppl.e20567
Zobrazit plný text záznamu
10
Clinical outcomes after whole genome sequencing in patients with metastatic non-small cell lung cancer
Autor: Stephen Yip, Yussanne Ma, Andrew J. Mungall, Yongjun Zhao, Cheryl Ho, Steven J.M. Jones, Howard John Lim, Daniel J. Renouf, Sophie Sun, Marco A. Marra, Janessa Laskin, Negar Chooback, Richard A. Moore, Yaoqing Shen, Martin R. Jones, Erin Pleasance, Erica S Tsang
Publikováno v: Journal of Clinical Oncology. 35:e20563-e20563
e20563 Background: The Personalized OncoGenomics (POG) program at the BC Cancer Agency integrates whole genome (DNA) and RNA sequencing into practice for metastatic malignancies. We examine patients with metastatic NSCLC and report the prevalence of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4864f709c3e49cf29977b86df14faa70
https://doi.org/10.1200/jco.2017.35.15_suppl.e20563
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje